Carl Icahn buys Amylin Pharmaceuticals Inc., Motorola Inc, Biogen Idec Inc., sells Compton Petroleum Corp., CSX Corp., Lincoln National Corp

Author's Avatar
May 20, 2008
Activist billionaire investor Carl Icahn is busy with deals these days. He is involved in the high profiled Microsoft Yahoo deal these days. Carl Icahn owns 26 stocks with a total value of $4.6 billion. These are the details of the buys and sells during the first quarter of 2008.


Carl Icahn buys Amylin Pharmaceuticals Inc., sells Compton Petroleum Corp., CSX Corp., Lincoln National Corp., Macy's Inc., TakeTwo Interactive Software Inc., Unum Group, BEA Systems Inc. during the 3-months ended 04/29/2008, according to the most recent filings of his investment company, Icahn Capital Management LP. Carl Icahn owns 26 stocks with a total value of $4.6 billion. These are the details of the buys and sells.





New Purchases: AMLN,


Added Positions: BIIB, ENZN, FOR, GFG, MOT,


Reduced Positions: JCP, PERY,


Sold Out: CMZ, CSX, LNC, M, TTWO, UNM, BEAS,





For the details of Carl Icahn's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Carl+Icahn


Added: Motorola Inc. (MOT, Financial)


Carl Icahn added to his holdings in Motorola Inc. by 91.26%. His purchase prices were between $9.21 and $14.99, with an estimated average price of $11.4. The impact to his portfolio due to this purchase was 11.05%. His holdings were 115,649,600 shares as of 04/29/2008.


Motorola, Inc. provides technologies, products, and services for mobile communications. It operates in three segments: Mobile Devices, Home and Networks Mobility, and Enterprise Mobility Solutions. Motorola Inc. has a market cap of $23 billion; its shares were traded at around $10.2 with P/S ratio of 0.66. The dividend yield of Motorola Inc. stocks is 2%.


Added: Biogen Idec Inc (BIIB, Financial)


Carl Icahn added to his holdings in Biogen Idec Inc by 20.49%. His purchase prices were between $55.22 and $62.2, with an estimated average price of $59.5. The impact to his portfolio due to this purchase was 2.25%. His holdings were 9,948,723 shares as of 04/29/2008.


Biogen Idec, Inc. engages in the development, manufacture, and commercialization of novel therapies primarily in the areas of oncology, neurology, immunology, and cardiology in the United States and internationally. Biogen Idec Inc has a market cap of $18.39 billion; its shares were traded at around $62.75 with a P/E ratio of 29.00 and P/S ratio of 5.48.


Added: FORESTAR RE GROUP (FOR, Financial)


Carl Icahn added to his holdings in FORESTAR RE GROUP by 130.8%. His purchase prices were between $19.05 and $27.95, with an estimated average price of $24.1. The impact to his portfolio due to this purchase was 0.8%. His holdings were 2,653,012 shares as of 04/29/2008.


Forestar Real Estate Group, Inc. engages in the real estate and natural resources businesses in the United States. The company operates through two segments, Real estate and Natural resources. FORESTAR RE GROUP has a market cap of $889.39 million; its shares were traded at around $24.98 with a P/E ratio of 35.63 and P/S ratio of 5.07.


Added: GUARANTY FIN GROUP (GFG, Financial)


Carl Icahn added to his holdings in GUARANTY FIN GROUP by 130.8%. His purchase prices were between $9.88 and $16.09, with an estimated average price of $13.1. The impact to his portfolio due to this purchase was 0.35%. His holdings were 2,653,012 shares as of 04/29/2008.


Guaranty Financial Group, Inc., through its subsidiary, Guaranty Bank, provides commercial and retail banking products and services in the United States. GUARANTY FIN GROUP has a market cap of $230.53 million; its shares were traded at around $6.18 with a P/E ratio of 5.62 and P/S ratio of 0.54.


Added: Enzon Inc. (ENZN, Financial)


Carl Icahn added to his holdings in Enzon Inc. by 39.64%. His purchase prices were between $8.16 and $9.25, with an estimated average price of $8.7. The impact to his portfolio due to this purchase was 0.14%. His holdings were 2,457,683 shares as of 04/29/2008.


Enzon Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development, manufacture, and commercialization of pharmaceutical products for the treatment of cancer and various life-threatening diseases in the United States, Europe. Enzon Inc. has a market cap of $390.77 million; its shares were traded at around $8.75 with a P/E ratio of 6.51 and P/S ratio of 2.03.


New Purchase: Amylin Pharmaceuticals Inc. (AMLN, Financial)


Carl Icahn initiated holdings in Amylin Pharmaceuticals Inc.. His purchase prices were between $25.1 and $36.46, with an estimated average price of $29.9. The impact to his portfolio due to this purchase was 3.99%. His holdings were 6,339,653 shares as of 04/29/2008.


Amylin Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of medicines for diabetes, obesity, and other diseases in the United States. Amylin Pharmaceuticals Inc. has a market cap of $4.38 billion; its shares were traded at around $31.95 with P/S ratio of 5.47.


Reduced: Perry Ellis International Inc. (PERY, Financial)


Carl Icahn reduced to his holdings in Perry Ellis International Inc. by 37.04%. His sale prices were between $12.84 and $22.39, with an estimated average price of $17.3. The impact to his portfolio due to this sale was 0.04%. Carl Icahn still held 129,715 shares as of 04/29/2008.


Perry Ellis International, Inc., together with its subsidiaries, engages in designing, sourcing, marketing, and licensing men and women apparel products in the United States and internationally. Perry Ellis International Inc. has a market cap of $352.95 million; its shares were traded at around $23.96 with a P/E ratio of 13.32 and P/S ratio of 0.43.


Reduced: J.C. Penney Company Inc. (JCP, Financial)


Carl Icahn reduced to his holdings in J.C. Penney Company Inc. by 98.08%. His sale prices were between $37.24 and $48.56, with an estimated average price of $42.5. The impact to his portfolio due to this sale was 0.03%. Carl Icahn still held 80,000 shares as of 04/29/2008.


J. C. Penney Company, Inc., through its subsidiary, J. C. Penney Corporation, Inc., sells merchandise and services to customers through its department stores and catalog/Internet channels. J.C. Penney Company Inc. has a market cap of $9.75 billion; its shares were traded at around $43.96 with a P/E ratio of 8.90 and P/S ratio of 0.50. The dividend yield of J.C. Penney Company Inc. stocks is 1.7%.


Sold Out: TakeTwo Interactive Software Inc. (TTWO, Financial)


Carl Icahn sold out his holdings in TakeTwo Interactive Software Inc.. His sale prices were between $14.71 and $26.5, with an estimated average price of $19.9. The impact to his portfolio due to this sale was less than 0.01%.


Take-Two Interactive Software, Inc. engages in the development, publication, and distribution of interactive software games designed for personal computers, video game consoles, and handheld platforms worldwide. TakeTwo Interactive Software Inc. has a market cap of $2.07 billion; its shares were traded at around $26.91 with P/S ratio of 2.20.


Sold Out: Macy's Inc. (M, Financial)


Carl Icahn sold out his holdings in Macy's Inc.. His sale prices were between $21.2 and $27.85, with an estimated average price of $23.9. The impact to his portfolio due to this sale was less than 0.01%.


Macy's, Inc., through its subsidiaries, operates department stores in the United States. Its retail stores sell a range of merchandise, including men's, women's, and children's apparel; and accessories, cosmetics, home furnishings, Macy's Inc. has a market cap of $10.43 billion; its shares were traded at around $24.82 with a P/E ratio of 12.55 and P/S ratio of 0.40. The dividend yield of Macy's Inc. stocks is 2.1%.


Sold Out: Lincoln National Corp. (LNC, Financial)


Carl Icahn sold out his holdings in Lincoln National Corp.. His sale prices were between $47.31 and $55.67, with an estimated average price of $51.7. The impact to his portfolio due to this sale was less than 0.01%.


Lincoln National Corporation, through its subsidiaries, engages in multiple insurance and investment management businesses primarily in the United States. Lincoln National Corp. has a market cap of $14.35 billion; its shares were traded at around $55.6 with a P/E ratio of 13.50 and P/S ratio of 1.36. The dividend yield of Lincoln National Corp. stocks is 3%.


Sold Out: Unum Group (UNM, Financial)


Carl Icahn sold out his holdings in Unum Group. His sale prices were between $20.48 and $24.01, with an estimated average price of $22.1. The impact to his portfolio due to this sale was less than 0.01%.


Unum Group provides group and individual disability products primarily in the United States and the United Kingdom. It also provides a portfolio of other insurance products, including long-term care insurance, life insurance, Unum Group has a market cap of $8.54 billion; its shares were traded at around $24.67 with a P/E ratio of 13.26 and P/S ratio of 0.81. The dividend yield of Unum Group stocks is 1.2%.


Sold Out: CSX Corp. (CSX)


Carl Icahn sold out his holdings in CSX Corp.. His sale prices were between $40.61 and $56.55, with an estimated average price of $47.8. The impact to his portfolio due to this sale was less than 0.01%.


CSX Corporation provides rail-based transportation services in North America. The company offers traditional rail service and the transport of intermodal containers and trailers. CSX Corp. has a market cap of $27.1 billion; its shares were traded at around $66.94 with a P/E ratio of 20.16 and P/S ratio of 2.57. The dividend yield of CSX Corp. stocks is 1.1%.


Sold Out: Compton Petroleum Corp. (CMZ)


Carl Icahn sold out his holdings in Compton Petroleum Corp.. His sale prices were between $9.08 and $12.03, with an estimated average price of $10.4. The impact to his portfolio due to this sale was less than 0.01%.


Compton Petroleum Corporation engages in the exploration, development, and production of natural gas, natural gas liquids, and crude oil in the Western Canada Sedimentary Basin in Canada. Compton Petroleum Corp. has a market cap of $1.63 billion; its shares were traded at around $12.64 with a P/E ratio of 12.96 and P/S ratio of 3.92.